In this week’s episode of the Everything Epigenetics podcast, Dr. Chiara Herzog and I talk about how epigenetics is making waves in the medical world and how it could change treatment. Translational scientist and research fellow Dr. Herzog provides insights from her role in the Biomarkers of Aging Consortium and her work on the TirolGESUND project, one of the largest multi-omic human lifestyle intervention trials to date. We investigate the potential applications of epigenetics in cancer detection, aging biomarkers, and preventive measures that could change the paradigm of healthcare from one that is reactive to one that is proactive. We also explore the fascinating potential of using epigenetic markers to anticipate disease before it manifests itself, particularly in the context of cancer research, and how this could impact the delivery of tailored healthcare.
In this podcast you’ll learn about:
– How Dr. Herzog’s background in neuroscience led her to epigenetics
– Recent breakthroughs in epigenetics and why they are promising to healthcare
– The potential of epigenetic markers to predict cancer risk and diagnose early stages of cancer
– The setup and goals of the TiroGESUND study focusing on intermittent fasting and smoking cessation
– The importance of studying epigenetic changes across different cell types and understanding the exposome
– How the exposome interacts with our epigenome and its implications for personalized medicine